Followers | 7 |
Posts | 1577 |
Boards Moderated | 0 |
Alias Born | 02/27/2014 |
Tuesday, May 19, 2015 9:13:25 AM
I don't agree with Paulo Santos' view that the company didn't disclose that it had issues with manufacturing. It told us that it was working on optimizing manufacturing, so what was hidden there?
It doesn't need to go down to too much detail as that would be telling competitors too much.
I found that the company was pretty straightforward regarding it's credit and manufacturing, by informing us about the bank's sentiment regarding it's loans and by discussing the transition to Capstone Nutrition....The guidance that the company gave us was based on these material facts, and it was upbeat....meaning that Musclepharm had issues meeting demands that exceeded certain levels in the beginning of Q2, but had no problem growing.
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM